Women less likely to get care for potentially fatal heart condition, study finds
Researchers found women are 11% less likely to be referred to a hospital specialist after a diagnosis of the heart valve disease aortic stenosis.
Academics said the findings show 'inequities in management and care of this common and serious condition' after they also found differences in care among south Asian and black patients as well as those from poorer backgrounds.
Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness.
The condition is more common in elderly people.
It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery.
If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death.
The analysis suggests some people are less likely to receive this treatment.
Experts from the University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England.
Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve.
Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods.
Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients.
South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre.
Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis.
'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice.
'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.'
Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation, which supported the research, and consultant cardiologist, said: 'This study of over 150,000 GP records has unveiled disparities in access to aortic valve treatment for women, south Asian and black people, and people living in more deprived communities.
'We don't yet have the full picture, but these findings are concerning and we need more research to understand what is driving the differences seen.
'This will be crucial to enable action to address any underlying causes stopping some people from having access to the heart valve treatment and care they need, when they need it.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
18-07-2025
- Irish Examiner
Older males who compete in endurance sports more likely to have heart scarring, study finds
Older male endurance athletes may be at higher risk of heart scarring and related complications, according to a new study. Sudden cardiac death is a "leading cause of mortality" in athletes, experts said as they set out to investigate whether endurance athletes had heart scarring and linked heart rhythm problems. Academics studied 106 former competitive cyclists and triathletes who exercise for more than 10 hours a week for at least 15 years. Experts from the University of Leeds scanned their hearts and had an implantable loop recorder fitted to assess their heart rhythms. They found that 50 of the 106 athletes (47%) had scarring on their hearts, particularly in the left ventricle - the main pumping chamber of the heart. This compares to 11% of 27 non-endurance athletes studied for comparison. During a two-year follow-up period they found that 22% of the athletes had an abnormal heart rhythm, according to the study published in the journal Circulation: Cardiovascular Imaging. They concluded that the athletes who had heart scarring were over 4.5 times more likely to experience an abnormal heart rhythm episode - which is linked with an increased risk of sudden cardiac arrest - compared to those without scarring. It is thought that among endurance athletes scarring could be caused by levels of exercise when the heart has to work even harder to pump blood. Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation and consultant cardiologist, said: "There's no doubt that exercise is good for our hearts - it helps to reduce blood pressure and cholesterol, manage our weight, and it boosts our mental health. But in some veteran male athletes, this early research suggests that intense exercise over many years may have affected their heart health. "More research in veteran endurance athletes - both in men and women - will be needed to identify the small number of people who have the kind of heart scarring, together with other risk factors, that mean their life could be saved by having an implantable defibrillator." One of the athletes who took part in the trial was Brian Cookson, keen cyclist and former president of British Cycling and Union Cycliste Internationale - cycling's world governing body. The 74-year-old grandfather from Whalley in Lancashire, England, said the trial could have saved his life. While training at the Manchester Velodrome he started feeling unwell and his sports watch recorded his heart rate had reached 238 beats per minute (bpm), and stayed that way for around 15 minutes. "I was pushing it a little bit on the track, but not absolutely full gas, as we say in cycling," Mr Cookson said. He contacted the team involved with the study who reviewed data from his implanted device to record his heart rhythm. They were able to see he had suffered an episode of ventricular tachycardia - an abnormally fast heartbeat where the heart's ventricles contract too quickly and do not pump blood around the body effectively. "The next day, I got a call. They said, 'Stop riding your bike, don't do anything more strenuous than walking until we can get you in here because we think you need an implantable cardioverter defibrillator (ICD)'," he said. He was fitted with one of the devices in August last year which shocks the heart if it goes into an abnormal rhythm. Mr Cookson, who is still cycling, said: "I keep a closer eye on my heart rate now and if I'm getting to 150bpm I'll start backing off. I'm so grateful to have been part of this study. It might well have saved my life. Without it, I might have carried on pushing myself until something more serious happened. Dr Peter Swoboda, associate professor in cardiology and consultant cardiologist at the University of Leeds, who led the study, said: "In our study, the athletes who experienced dangerous heart rhythms often had symptoms first. "I'd encourage anyone who experiences blackouts, dizziness, chest pain or breathlessness, whether during sport or at rest, to speak to their doctor and get it checked out. "These results shouldn't put people off regular exercise. "Our study focused on a very select group, and not all the athletes involved were found to have scarring in their hearts. We can all benefit from being more active, and this study is an important step towards helping people take part in sport as safely as possible." Read More How to start lifting weights and build muscle in mid-life
Irish Examiner
04-06-2025
- Irish Examiner
Women less likely to get care for potentially fatal heart condition, study finds
Women are less likely than men to be given treatment for a potentially fatal heart condition, according to a new analysis. Researchers found women are 11% less likely to be referred to a hospital specialist after a diagnosis of the heart valve disease aortic stenosis. Academics said the findings show 'inequities in management and care of this common and serious condition' after they also found differences in care among south Asian and black patients as well as those from poorer backgrounds. Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness. The condition is more common in elderly people. It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery. If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death. The analysis suggests some people are less likely to receive this treatment. Experts from the University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England. Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve. Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods. Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients. South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre. Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis. 'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice. 'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.' Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation, which supported the research, and consultant cardiologist, said: 'This study of over 150,000 GP records has unveiled disparities in access to aortic valve treatment for women, south Asian and black people, and people living in more deprived communities. 'We don't yet have the full picture, but these findings are concerning and we need more research to understand what is driving the differences seen. 'This will be crucial to enable action to address any underlying causes stopping some people from having access to the heart valve treatment and care they need, when they need it.'
Irish Examiner
01-06-2025
- Irish Examiner
Exercise slashes risk of death in patients with colon cancer
Exercise slashes the risk of death in patients with colon cancer by more than a third, a trial has found. Physical activity could also prevent the disease from coming back, as well as lifting mood, reducing fatigue and boosting strength, according to researchers. Colon cancer develops in the part of the large intestine known as the colon, part of the large bowel, which also comprises the rectum and anus. It can sometimes be referred to as bowel cancer or colorectal cancer. Our study gives clear, encouraging evidence that physical activity can reduce the risk of cancer returning for some people with colon cancer The CO21 Challenge trial, led by researchers in Northern Ireland and Canada, involved 889 people with colon cancer from six countries. All patients had had surgery and chemotherapy for their cancer and were deemed well enough to exercise, but were not meeting recommended physical activity levels. Around half were given a three-year tailored exercise programme, which included the likes of brisk walking, circuit classes, cycling, or swimming. The plan included in-person coaching sessions for the first six months, as well as regular meetings with a physical activity consultant. We now need to work with policymakers and healthcare providers to embed exercise into treatment plans where appropriate The other group were offered materials that promoted exercise and nutrition. The study found that after five years, the risk of dying, relapse or developing a new cancer was 28% lower in the group with a tailored exercise plan. After eight years, patients in the physical activity group had a 37% lower risk of death. Professor Vicky Coyle, UK lead researcher for the trial and clinical professor at Queen's University Belfast, said: 'During the trial, we supported people to reach their weekly exercise target in a way that worked for them. 'This could be a brisk walk for around 40 minutes every day, but some patients were also doing circuit classes, cycling, swimming, and many other activities. We know that physical activity regulates several key biological processes that could explain these results, and further research will help us uncover why exercise is having such a positive impact 'Our study gives clear, encouraging evidence that physical activity can reduce the risk of cancer returning for some people with colon cancer. 'We now need to work with policymakers and healthcare providers to embed exercise into treatment plans where appropriate.' Dr Joe Henson, associate professor in lifestyle medicine at the University of Leicester, said: 'Leading the exercise sessions in Leicester, I saw first-hand that this reduced fatigue, lifted people's mood, and boosted their physical strength. 'We know that physical activity regulates several key biological processes that could explain these results, and further research will help us uncover why exercise is having such a positive impact.' The findings, published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology (ASCO), could 'transform clinical practice', according to experts. This trial has the potential to transform clinical practice, but only if health services have the necessary funding and staff to make it a reality for patients Caroline Geraghty, senior specialist information nurse at Cancer Research UK, said: 'Being active has many benefits, and this study shows that exercise doesn't only improve well-being – it can also boost people's chances of surviving colon cancer. 'Everyone recovering from cancer should have access to tailored support to help them live longer, better lives. 'This trial has the potential to transform clinical practice, but only if health services have the necessary funding and staff to make it a reality for patients. 'It's important to remember that every cancer journey is different – starting new activities after treatment can feel overwhelming, and it may not be the right option for everyone. Take things at your own pace and speak to your doctor to discuss what is safe for you.' Professor Peter Johnson, NHS national clinical director for cancer, said: 'These exciting findings add to the growing evidence of the benefits of physical activity for people affected by cancer, not just in helping them be fitter for treatment and boosting their immediate recovery, but reducing the risk of the disease coming back. 'This is why we've asked cancer alliances across the country to look at ways to encourage and support patients to do physical activity and ensure every healthcare professional they see can help them be in the best possible place – both physically and mentally – before, during and after treatment.'
